Cargando…

Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification

BACKGROUND: GalNAc-T3 catalyzes initial glycosylation of mucin-type O-linked protein involved in proliferation, adhesion, and migration of tumor cells. This study was performed to explore the relationships of the expression of GalNAc-T3 in small peripheral lung adenocarcinoma, especially as an indic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shilei, Guo, Tao, Li, Jinxiu, Uramoto, Hidetaka, Guan, Hongwei, Deng, Wuguo, Gu, Chundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629976/
https://www.ncbi.nlm.nih.gov/pubmed/26604783
http://dx.doi.org/10.2147/OTT.S93486
_version_ 1782398648960679936
author Zhao, Shilei
Guo, Tao
Li, Jinxiu
Uramoto, Hidetaka
Guan, Hongwei
Deng, Wuguo
Gu, Chundong
author_facet Zhao, Shilei
Guo, Tao
Li, Jinxiu
Uramoto, Hidetaka
Guan, Hongwei
Deng, Wuguo
Gu, Chundong
author_sort Zhao, Shilei
collection PubMed
description BACKGROUND: GalNAc-T3 catalyzes initial glycosylation of mucin-type O-linked protein involved in proliferation, adhesion, and migration of tumor cells. This study was performed to explore the relationships of the expression of GalNAc-T3 in small peripheral lung adenocarcinoma, especially as an indicator of prognosis. MATERIALS AND METHODS: A retrospective analysis of the patients with small peripheral lung lesions, including 106 adenocarcinoma and two precancerous lesions (atypical adenomatous hyperplasia and adenocarcinoma in situ) after complete surgical resection, was launched. Expression of GalNAc-T3 was examined using immunohistochemistry staining on primary tumor specimens, and the tumors were reclassified in light of the IASLC/ATS/ERS (International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society) adenocarcinoma classifications followed by grading and scoring. Moreover, reverse transcription polymerase chain reaction and Western blot were used to study the expression of GalNAc-T3 in vivo. RESULTS: The low expression of GalNAc-T3 was found in the cytoplasm of tumor cells in 56 of 108 patients (51.9%) and was associated with IASLC/ATS/ERS classification of high risk groups (P=0.007), high Sica score (P=0.036), poorly differentiated tumor (P=0.023), poor tumor-node-metastasis (TNM) stage (P=0.007), pleural invasion (P=0.007), and vascular invasion (P<0.001) by Pearson’s chi-squared test, but not with sex, age, smoking status, concentration of carcinoembryonic antigen, and lymph node metastasis. In logistic regression analysis, low GalNAc-T3 expression was only correlated with high-ranking TNM stage (odds ratio [OR] =8.975, 95% confidence interval [CI]: 1.797–44.661), vascular invasion (OR =5.668, 95% CI: 1.827–17.578), and the higher risk grade (low risk grade: OR =0.141, 95% CI: 0.027–0.719; moderate risk grade: OR =0.122, 95% CI: 0.017–40.871). The low expression of the GalNAc-T3 usually in adenocarcinoma cell lines was compared with normal bronchial epithelium cell line. Based on the univariate and multivariate analysis, poor TNM stage (P<0.001), pleural invasion (hazard ratio [HR]: 7.958, P=0.021), vascular invasion (HR: 2.403, P=0.040), and low GalNAc-T3 expression (HR: 3.317, P=0.016) were shown to be independently associated with an unfavorable prognosis. However, IASLC/ATS/ERS classification of risk groups and Sica score (P=0.034 and P=0.032, respectively) was correlated with overall survival on Kaplan–Meier method but not Cox regression model. CONCLUSION: GalNAc-T3 expression was correlated with the IASLC/ATS/ERS classification and also associated with prognosis of patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma.
format Online
Article
Text
id pubmed-4629976
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46299762015-11-24 Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification Zhao, Shilei Guo, Tao Li, Jinxiu Uramoto, Hidetaka Guan, Hongwei Deng, Wuguo Gu, Chundong Onco Targets Ther Original Research BACKGROUND: GalNAc-T3 catalyzes initial glycosylation of mucin-type O-linked protein involved in proliferation, adhesion, and migration of tumor cells. This study was performed to explore the relationships of the expression of GalNAc-T3 in small peripheral lung adenocarcinoma, especially as an indicator of prognosis. MATERIALS AND METHODS: A retrospective analysis of the patients with small peripheral lung lesions, including 106 adenocarcinoma and two precancerous lesions (atypical adenomatous hyperplasia and adenocarcinoma in situ) after complete surgical resection, was launched. Expression of GalNAc-T3 was examined using immunohistochemistry staining on primary tumor specimens, and the tumors were reclassified in light of the IASLC/ATS/ERS (International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society) adenocarcinoma classifications followed by grading and scoring. Moreover, reverse transcription polymerase chain reaction and Western blot were used to study the expression of GalNAc-T3 in vivo. RESULTS: The low expression of GalNAc-T3 was found in the cytoplasm of tumor cells in 56 of 108 patients (51.9%) and was associated with IASLC/ATS/ERS classification of high risk groups (P=0.007), high Sica score (P=0.036), poorly differentiated tumor (P=0.023), poor tumor-node-metastasis (TNM) stage (P=0.007), pleural invasion (P=0.007), and vascular invasion (P<0.001) by Pearson’s chi-squared test, but not with sex, age, smoking status, concentration of carcinoembryonic antigen, and lymph node metastasis. In logistic regression analysis, low GalNAc-T3 expression was only correlated with high-ranking TNM stage (odds ratio [OR] =8.975, 95% confidence interval [CI]: 1.797–44.661), vascular invasion (OR =5.668, 95% CI: 1.827–17.578), and the higher risk grade (low risk grade: OR =0.141, 95% CI: 0.027–0.719; moderate risk grade: OR =0.122, 95% CI: 0.017–40.871). The low expression of the GalNAc-T3 usually in adenocarcinoma cell lines was compared with normal bronchial epithelium cell line. Based on the univariate and multivariate analysis, poor TNM stage (P<0.001), pleural invasion (hazard ratio [HR]: 7.958, P=0.021), vascular invasion (HR: 2.403, P=0.040), and low GalNAc-T3 expression (HR: 3.317, P=0.016) were shown to be independently associated with an unfavorable prognosis. However, IASLC/ATS/ERS classification of risk groups and Sica score (P=0.034 and P=0.032, respectively) was correlated with overall survival on Kaplan–Meier method but not Cox regression model. CONCLUSION: GalNAc-T3 expression was correlated with the IASLC/ATS/ERS classification and also associated with prognosis of patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma. Dove Medical Press 2015-10-27 /pmc/articles/PMC4629976/ /pubmed/26604783 http://dx.doi.org/10.2147/OTT.S93486 Text en © 2015 Zhao et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhao, Shilei
Guo, Tao
Li, Jinxiu
Uramoto, Hidetaka
Guan, Hongwei
Deng, Wuguo
Gu, Chundong
Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
title Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
title_full Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
title_fullStr Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
title_full_unstemmed Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
title_short Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
title_sort expression and prognostic value of galnac-t3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after iaslc/ats/ers classification
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629976/
https://www.ncbi.nlm.nih.gov/pubmed/26604783
http://dx.doi.org/10.2147/OTT.S93486
work_keys_str_mv AT zhaoshilei expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification
AT guotao expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification
AT lijinxiu expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification
AT uramotohidetaka expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification
AT guanhongwei expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification
AT dengwuguo expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification
AT guchundong expressionandprognosticvalueofgalnact3inpatientswithcompletelyresectedsmall2cmperipherallungadenocarcinomaafteriaslcatsersclassification